Acadia Pharmaceuticals Stock Market Value
| ACAD Stock | USD 16.82 0.25 1.46% |
| Symbol | ACADIA |
Is ACADIA Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ACADIA Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ACADIA Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ACADIA Pharmaceuticals.
| 01/21/2024 |
| 04/20/2024 |
If you would invest 0.00 in ACADIA Pharmaceuticals on January 21, 2024 and sell it all today you would earn a total of 0.00 from holding ACADIA Pharmaceuticals or generate 0.0% return on investment in ACADIA Pharmaceuticals over 90 days. ACADIA Pharmaceuticals is related to or competes with Madrigal Pharmaceuticals, Viking Therapeutics, Sarepta Therapeutics, Hepion Pharmaceuticals, PTC Therapeutics, Reviva Pharmaceuticals, and Athira PharmaInc. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small mole... More
ACADIA Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ACADIA Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ACADIA Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 21.72 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 2.65 |
ACADIA Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ACADIA Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ACADIA Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use ACADIA Pharmaceuticals historical prices to predict the future ACADIA Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (1.12) | |||
| Treynor Ratio | 3.09 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ACADIA Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ACADIA Pharmaceuticals Backtested Returns
ACADIA Pharmaceuticals retains Efficiency (Sharpe Ratio) of -0.24, which signifies that the company had a -0.24% return per unit of risk over the last 3 months. ACADIA Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ACADIA Pharmaceuticals' variance of 9.34, and Market Risk Adjusted Performance of 3.1 to double-check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of -0.24, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ACADIA Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, ACADIA Pharmaceuticals is likely to outperform the market. ACADIA Pharmaceuticals has an expected return of -0.73%. Please make sure to confirm ACADIA Pharmaceuticals total risk alpha, potential upside, and the relationship between the standard deviation and maximum drawdown , to decide if ACADIA Pharmaceuticals performance from the past will be repeated at some future date.
Auto-correlation | 0.76 |
Good predictability
ACADIA Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between ACADIA Pharmaceuticals time series from 21st of January 2024 to 6th of March 2024 and 6th of March 2024 to 20th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ACADIA Pharmaceuticals price movement. The serial correlation of 0.76 indicates that around 76.0% of current ACADIA Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.85 | |
| Residual Average | 0.0 | |
| Price Variance | 3.82 |
ACADIA Pharmaceuticals lagged returns against current returns
Autocorrelation, which is ACADIA Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ACADIA Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of ACADIA Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that ACADIA Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ACADIA Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ACADIA Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ACADIA Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ACADIA Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
ACADIA Pharmaceuticals Lagged Returns
When evaluating ACADIA Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ACADIA Pharmaceuticals stock have on its future price. ACADIA Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ACADIA Pharmaceuticals autocorrelation shows the relationship between ACADIA Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in ACADIA Pharmaceuticals.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ACADIA Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ACADIA Pharmaceuticals' short interest history, or implied volatility extrapolated from ACADIA Pharmaceuticals options trading.
Pair Trading with ACADIA Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACADIA Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACADIA Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against ACADIA Stock
| 0.72 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.49 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.44 | ZNTL | Zentalis PharmaceuticalsL Buyout Trend | PairCorr |
The ability to find closely correlated positions to ACADIA Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ACADIA Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ACADIA Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ACADIA Pharmaceuticals to buy it.
The correlation of ACADIA Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ACADIA Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ACADIA Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ACADIA Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out ACADIA Pharmaceuticals Correlation, ACADIA Pharmaceuticals Volatility and ACADIA Pharmaceuticals Alpha and Beta module to complement your research on ACADIA Pharmaceuticals. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.Note that the ACADIA Pharmaceuticals information on this page should be used as a complementary analysis to other ACADIA Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
ACADIA Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.